Diabetes

Significantly better than standard of care at 12 and 24 weeks

This "is a moral issue," Sen. Bernie Sanders said during the hearing

Beta-hydroxybutyrate-based stopping point reduced burden on patients

Serious limitations noted of attempt to compare GLP-1 agonists, SGLT-2 inhibitors, however

Helped diabetics cut down on daily insulin dose, body weight

But not waiting for repeat glucose-tolerance testing confirmation didn't help mom, trial shows

Diabetic nephropathy was most common of the fatal complications, study showed

Also in TTHealthWatch: umbilical cord blood analysis and obesity

Health news and commentary from around the Web gathered by MedPage Today staff

Keeping most readings under 9% avoided elevated dementia risk

If finerenone isn't available, try spironolactone, said researcher

Population-based study shows older patients with poorly controlled diabetes at particular risk

Early work suggests a connection, but experts say more investigation is needed

Reduced risk only seen in physically active patients, Taiwanese study found